Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories Forward

News   Dec 15, 2017 | Original story from Wyss Institute

 
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories Forward

Single-stranded origami technology is based on design rules that can be used to cross DNA strands in and out of single stranded regions to build large nanostructures. Credit: Molgraphics

 
 
 

RELATED ARTICLES

Machine Learning Helps Predict Schizophrenia Treatment Outcomes

News

New research that used a machine-learning algorithm to investigate MRI images of schizophrenia patients has successfully identified response to antipsychotic treatment in 4 out of 5 patients.

READ MORE

Fragile X: Drug Strategy Could Alleviate Behavioral & Cellular Deficiencies

News

Research in mice shows that a pharmacological strategy can alleviate multiple behavioral and cellular deficiencies in a mouse model of fragile X syndrome (FXS), the most common inherited form of intellectual disability and a major single-gene cause of autism spectrum disorders.

READ MORE

Pfizer to Organize for Future Growth

News

Pfizer Inc. announced it will organize the company into three businesses.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Biopharma Drug Discovery Genomics Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy